Berkshire Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Berkshire Asset Management's NVS Position: Q1 2020 in Review
Berkshire Asset Management sold out of Novartis (NVS) in Q1 2020, closing a stake of 2,153 shares — an estimated $204K sold.
Berkshire Asset Management first reported a position in NVS in Q2 2015 and held it in 14 quarters. The position peaked at $1.75M in Q3 2016. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.
- Berkshire Asset Management reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
- Berkshire Asset Management sold 2,153 Novartis shares in Q1 2020, an estimated $204K.
- Berkshire Asset Management first reported a position in Novartis in Q2 2015 and held it in 14 quarters.
- Berkshire Asset Management's Novartis position peaked at $1.75M in Q3 2016.
- 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.
Based on Berkshire Asset Management's 13F filing for Q1 2020, filed 13 May 2020.